Joao Gorgulho

5PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 06, 2026
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

|Aug 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients.

Joao Gorgulho, Timo Trenkner, Eva Kinkel

|Oct 05, 2024
Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients.

Joao Gorgulho, Johann von Felden

|Jan 17, 2024
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies.

Joao Gorgulho, Christoph Roderburg, Fabian Beier

|Apr 23, 2021
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies.

Joao Gorgulho, Christoph Roderburg, Felix Heymann

Pageof 1

Frequent Collaborators

3 joint publications

Johann von Felden

1 joint publications

Sven H Loosen

1 joint publications

Tim H Brümmendorf

1 joint publications

Sven Peine